Urinary Tract Infections in Patients With Severe Renal Disease
- 23 August 1976
- journal article
- research article
- Published by American Medical Association (AMA)
- Vol. 236 (8) , 946-948
- https://doi.org/10.1001/jama.1976.03270090040026
Abstract
Twelve patients with severe renal failure and intercurrent urinary tract infections were treated with either ampicillin trihydrate, 500 mg four times a day, or trimethoprim-sulfamethoxazole, two tablets (80 mg trimethoprim, 400 mg sulfamethoxazole) twice a day. All patients achieved bacteriologic cure, including six with proved upper tract infection. Serum levels of all drugs were increased to values above those seen in normal subjects without adverse effects. Urine concentrations of trimethoprim, 28.6μg/ml, and ampicillin, 88.6μg/ml, were well above the minimum inhibitory concentrations of urinary pathogens. Urine sulfamethoxazole concentrations were less than 10μg/ml in four of the six patients treated; however, this did not hamper bacteriologic success. It is concluded that both drugs can be used to treat urinary tract infections in patients with renal functional impairment. (JAMA236:946-948, 1976)Keywords
This publication has 4 references indexed in Scilit:
- Effect of Trimethoprim-Sulfamethoxazole on the Renal Excretion of Creatinine in ManJournal of Urology, 1975
- USE OF CO-TRIMOXAZOLE IN CHRONIC RENAL FAILUREThe Lancet, 1975
- HUMAN PHARMACOKINETICS OF A SULFAMETHOXAZOLE‐TRIMETHOPRIM COMBINATIONActa Medica Scandinavica, 1972
- Oral Cephalexin and Ampicillin: Antimicrobial Activity, Recovery in Urine, and Persistence in Blood of Uremic PatientsAnnals of Internal Medicine, 1970